Research programme: oxapenems - Micron Research/Amura

Drug Profile

Research programme: oxapenems - Micron Research/Amura

Alternative Names: AM 119; AM 122

Latest Information Update: 28 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Amura; Micron Research
  • Class
  • Mechanism of Action Beta lactamase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Bacterial infections

Most Recent Events

  • 28 Aug 2006 This programme is still in active development
  • 07 Jan 2004 This programme is still in active development
  • 18 Jun 2002 Preclinical data have been added to the drug interactions and Bacterial infections antimicrobial activity sections ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top